Clinical Trial Update: Regulatory Nebilet PMS

View source ↗

Summary

This is a completed post-marketing surveillance (PMS) study for Nebilet (nebivolol) conducted by GlaxoSmithKline. The trial monitored safety in patients with hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Nebilet (nebivolol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension, Heart Failure | Status: COMPLETED